MEGHAN POCIUS: Open Payments
NPI 1326297920 · WHITE PLAINS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 68 payments from 15 companies in 2025. Trend: 2023 $823 · 2024 $2,247 · 2025 $1,476
Food & beverage: $1,411Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $323 |
| Novartis Pharmaceuticals Corporation | 5 | $148 |
| UCB, Inc. | 9 | $142 |
| GENZYME CORPORATION | 6 | $140 |
| ABBVIE INC. | 5 | $124 |
| Amgen Inc. | 4 | $113 |
| Organon LLC | 4 | $98 |
| Incyte Corporation | 4 | $95 |
| PFIZER INC. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, OTEZLA, OPZELURA, COSENTYX, VTAMA.
Industry payments across MD — which companies pay providers there.
